MACHATHA STEPHEN (Chief Development Officer) sold 9.1% of their position (22.07K shares) of ALDEYRA THERAPEUTICS, INC. on the open market
Open‑market sale worth $113.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/13/2025ACC: 0000950170-25-108210
Officer· Chief Development Officer
Since Dec 2020
-22.07K
Net shares
Net seller
$113.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
22.07K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−22.07K
Price / share
$5.15
Trade value
$113.71K
% of position
9.1%
8/11/2025
243.87K→221.80K
Total
Net shares
−22.07K
Net value
-$113.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2025 | S · Sale | −22.07K | $5.15 | $113.71K | 9.1% | 243.87K | 221.80K |
| Total | −22.07K | -$113.71K | ||||||
Derivative Transactions0
No derivative transactions reported